Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers Essential Hypertension”

38 trials

Showing 20 of 38 results

Early research (Phase 1)Study completedNCT06889012
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult Volunteers

Who this might be right for
Essential HypertensionPrimary Hypercholesterolemia
Boryung Pharmaceutical Co., Ltd 60
Early research (Phase 1)Study completedNCT01842256
What this trial is testing

Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.

Who this might be right for
Essential HypertensionHyperlipidemia
Chong Kun Dang Pharmaceutical 24
Not applicableStudy completedNCT03258489
What this trial is testing

Effects of TENS and IES on the Autonomous Balance of Normotens Volunteers and Hypertensive Patients

Who this might be right for
Healthy VolunteersHypertension, Essential
Universidade Federal de Santa Maria 60
Early research (Phase 1)Study completedNCT01289886
What this trial is testing

Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 40
Early research (Phase 1)Study completedNCT06744127
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 Under Fasting Conditions

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 58
Early research (Phase 1)Study completedNCT06744426
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fasting Conditions

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 60
Early research (Phase 1)Study completedNCT06501586
What this trial is testing

Study of SGB-3908 in Healthy Subjects and Mildly Hypertensive Subjects

Who this might be right for
Hypertension,Essential
Suzhou Sanegene Bio Inc. 40
Early research (Phase 1)Study completedNCT06184269
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of "BR1017-1" and Co-administration of "BR1017-1A" and "BR1017-1B"

Who this might be right for
Essential HypertensionPrimary Hypercholesterolemia
Boryung Pharmaceutical Co., Ltd 58
Early research (Phase 1)Looking for participantsNCT06823947
What this trial is testing

Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension

Who this might be right for
Healthy Volunteers Essential Hypertension
Kyowa Kirin Co., Ltd. 160
Early research (Phase 1)Study completedNCT06744439
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 49
Early research (Phase 1)Study completedNCT01289899
What this trial is testing

Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 16
Early research (Phase 1)Study completedNCT06889064
What this trial is testing

Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 28
Early research (Phase 1)Looking for participantsNCT07282145
What this trial is testing

Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers

Who this might be right for
Essential Hypertension
Bichedam Co., Ltd. 56
Early research (Phase 1)Study completedNCT01246193
What this trial is testing

CKD-828(80/2.5mg) Pharmacokinetic Study

Who this might be right for
Hypertension
Chong Kun Dang Pharmaceutical 65
Early research (Phase 1)Study completedNCT00938132
What this trial is testing

A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 15
Early research (Phase 1)Study completedNCT01352689
What this trial is testing

CKD-828(80/2.5mg) Pharmacokinetic Study_2nd

Who this might be right for
Hypertension
Chong Kun Dang Pharmaceutical 67
Early research (Phase 1)Study completedNCT06226727
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-1" and "BR1019-2"

Who this might be right for
Type 2 Diabetes MellitusEssential Hypertension
Boryung Pharmaceutical Co., Ltd 52
Early research (Phase 1)Study completedNCT06636877
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers

Who this might be right for
Essential HypertensionType 2 Diabetes
Boryung Pharmaceutical Co., Ltd 52
Early research (Phase 1)Study completedNCT00991783
What this trial is testing

Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 14
Early research (Phase 1)Study completedNCT00938197
What this trial is testing

Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 34
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation